New insights in the outbreak pattern of Mycoplasma pneumoniae

International Journal of Medical Microbiology

Volumn 305, Issue 7, 2015, Pages 705-708

  Jacobs, Enno ^a   Ehrhardt, Ingrid ^b   Dumke, Roger ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Institute for Medical Microbiology   (Germany)

Author keywords

Community acquired pneumonia; Detection; Epidemiology; Mycoplasma pneumoniae; Typing

Indexed keywords

ADHESIN; BACTERIAL PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENDEMIC DISEASE; EPIDEMIC; EPIDEMIOLOGICAL DATA; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR TYPING; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; RESPIRATORY TRACT EXAMINATION; SEQUENCE ANALYSIS; SERODIAGNOSIS; TIME; ADOLESCENT; ADULT; CHILD; CLASSIFICATION; FEMALE; GENETIC VARIATION; GENETICS; GENOTYPE; GERMANY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PNEUMONIA, MYCOPLASMA; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DISEASE OUTBREAKS; FEMALE; GENETIC VARIATION; GENOTYPE; GERMANY; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; YOUNG ADULT;

EID: 84944276439     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.08.021     Document Type: Article

References (41)

1. Atkinson T.P., Balish M.F., Waites K.B. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol. Rev. 2008, 32:956-973.
2. Atkinson T.P., Waites K.B. Mycoplasma pneumoniae infections in childhood. Pediatr. Infect. Dis. J. 2014, 33:92-94.
3. von Baum H., Welte T., Marre R., Suttorp N., Lück C., Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect. Dis. 2009, 9:62.
4. Blystad H., Ånestad G., Vestrheim D.F., Madsen S., Rønning K. Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill. 2012, 17. pii: 20074.
5. Citti C., Blanchard A. Mycoplasmas and their host: emerging and re-emerging minimal pathogens. Trends Microbiol. 2013, 21:196-203.
6. Chalker V., Stocki T., Litt D., Bermingham A., Watson J., Fleming D., Harrison T. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012, 17. pii: 20081.
7. Dandekar T., Huynen M., Regula J.T., Ueberle B., Zimmermann C.U., Andrade M.A., Doerks T., Sánchez-Pulido L., Snel B., Suyama M., Yuan Y.P., Herrmann R., Bork P. Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames. Nucleic Acids Res. 2000, 28:3278-3288.
8. Degrange S., Cazanave C., Charron A., Renaudin H., Bebear C., Bebear C.M. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J. Clin. Microbiol. 2009, 47:914-923.
9. Dumke R., von Baum H., Lück P.C., Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin. Microbiol. Infect. 2010, 16:613-616.
10. Dumke R., Catrein I., Pirkl E., Herrmann R., Jacobs E. Subtyping of Mycoplasma pneumoniae isolates based on extended genome sequencing and on expression profiles. Int. J. Med. Microbiol. 2003, 292:513-525.
11. Dumke R., Catrein I., Herrmann R., Jacobs E. Preference, adaptation and survival of Mycoplasma pneumoniae subtypes in an animal model. Int. J. Med. Microbiol. 2004, 294:149-155.
12. Dumke R., Jacobs E. Culture-independent multi-locus variable-number tandem-repeat analysis (MLVA) of Mycoplasma pneumoniae. J. Microbiol. Methods 2011, 86:393-396.
13. Dumke R., Lück C., Jacobs E. Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012. Antimicrob. Agents Chemother. 2013, 57:3460.
14. Dumke R., Lück P.C., Schaefer C., Noppen C., von Baum H., Marre R., Jacobs E. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J. Clin. Microbiol. 2006, 44:2567-2570.
15. Dumke R., Schnee C., Pletz M.W., Rupp J., Jacobs E., Sachse K., Rohde G., CAPNETZ Study Group Epidemiological, clinical and genetic characteristics of epidemic Mycoplasma pneumoniae infections in relation to Chlamydia spp. infections in Germany. Emerg. Infect. Dis. 2015, 21:426-434.
16. Dumke R., Schurwanz N., Lenz M., Schuppler M., Lück C., Jacobs E. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J. Clin. Microbiol. 2007, 45:2726-2730.
17. Hames C., Halbedel S., Hoppert M., Frey J., Stülke J. Glycerol metabolism is important for cytotoxicity of Mycoplasma pneumoniae. J. Bacteriol. 2009, 191:747-753.
18. Kannan T.R., Baseman J.B. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc. Natl. Acad. Sci. USA 2006, 103:6724-6729.
19. Klapdor B., Ewig S., Pletz M.W., Rohde G., Schütte H., Schaberg T., Welte T., CAPNETZ Study Group. Community-acquired pneumonia in younger patients is an entity on its own. Eur. Respir. J. 2012, 39:1156-1161.
20. Krause D.C., Balish M.F. Cellular engineering in a minimal microbe: structure and assembly of the terminal organelle of Mycoplasma pneumoniae. Mol. Microbiol. 2004, 51:917-924.
21. Kühner S., van Noort V., Betts M.J., Leo-Macias A., Batisse C., Rode M., Yamada T., Maier T., Bader S., Beltran-Alvarez P., Castaño-Diez D., Chen W.H., Devos D., Güell M., Norambuena T., Racke I., Rybin V., Schmidt A., Yus E., Aebersold R., Herrmann R., Böttcher B., Frangakis A.S., Russell R.B., Serrano L., Bork P., Gavin A.C. Proteome organization in a genome-reduced bacterium. Science 2009, 326:1235-1240.
22. Linde A., Ternhag A., Torner A., Claesson B. Antibiotic prescriptions and laboratory-confirmed cases of Mycoplasma pneumoniae during the epidemic in Sweden in 2011. Euro Surveill. 2012, 17. pii: 20082.
23. Loens K., Goossens H., Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29:1055-1069.
24. Meyer Sauteur P.M., Jacobs B.C., Spuesens E.M., Jacobs E., Nadal D., Vink C., van Rossum A.M. Antibody response to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis. PLOS Pathog. 2014, 10:e1003983.
25. Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J. Infect. Chemother. 2010, 16:162-169.
26. Nilsson A.C., Björkman P., Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008, 8:93-100.
27. Nilsson A.C., Björkman P., Welinder-Olsson C., Widell A., Persson K. Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype. BMC Infect. Dis. 2010, 10:39.
28. Onozuka D., Chaves L.F. Climate variability and nonstationary dynamics of Mycoplasma pneumoniae pneumonia in Japan. PLOS ONE 2014, 9:e95447.
29. Pereyre S., Renaudin H., Charron A., Bebear C. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. Emerg. Infect. Dis. 2012, 18:343-345.
30. Pereyre S., Touati A., Petitjean-Lecherbonnier J., Charron A., Vabret A., Bébéar C. The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin. Microbiol. Infect. 2013, 19:E212-E217.
31. Polkowska A., Harjunpää A., Toikkanen S., Lappalainen M., Vuento R., Vuorinen T., Kauppinen J., Flinck H., Lyytikäinen O. Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011. Euro Surveill. 2012, 17. pii: 20072.
32. Qu J., Yu X., Liu Y., Yin Y., Gu L., Cao B., Wang C. Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLOS ONE 2013, 8:e82174.
33. Razin S., Jacobs E. Mycoplasma adhesion. J. Gen. Microbiol. 1992, 138:407-422.
34. Rocha E.P.C., Blanchard A. Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution. Nucleic Acids Res. 2002, 30:2031-2042.
35. Spuesens E.B.M., Fraaij P.L.A., Visser E.G., Hoogenboezem T., Hop W.C.J., van Adrichem L.N.A., Weber F., Moll H.A., Broekman B., Berger M.Y., van Rijsoort-Vos T., van Belkum A., Schutten M., Pas S.D., Osterhaus A.D., Hartwig N.G., Vink C., van Rossum A.M. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLOS Med. 2013, 10:e1001444.
36. Spuesens E.B.M., Oduber M., Hoogenboezem T., Sluijter M., Hartwig N.G., van Rossum A.M.C., Vink C. Sequence variations in RepMP2/3 and RepMP4 elements reveal intragenomic homologous DNA recombination events in Mycoplasma pneumoniae. Microbiology 2009, 155:2182-2196.
37. Sun H., Xue G., Yan C., Li S., Cao L., Yuan Y., Zhao H., Feng Y., Wang L., Fan Z. Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLOS ONE 2013, 8:e64607.
38. Uldum S.A., Bangsborg J.M., Gahrn-Hansen B., Ljung R., Molvadgaard M., Fons Petersen R., Wiid Svarrer C. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012, 17. pii: 20073.
39. Waites K.B., Talkington D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 2004, 17:697-728.
40. Torres A., Peetermans W.E., Viegi G., Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 2013, 68:1057-1065.
41. Welte T., Torres A., Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012, 67:71-79.